Harrow (HROW)
Commercializes branded eye medicines and ImprimisRx compounding for US ophthalmology.
$33.85
vs last close−0.60 (−1.74%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 47 days
EPS estimate
$0.16
Revenue estimate
$99.1M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.24−$0.50$0.14$0.03$0.18−$0.74−$0.46Pending
Estimate$0.08$0.02$0.01$0.22$0.40−$0.43−$0.18$0.16
Surprise+192.7%−2,600.0%+1,754.3%−86.4%−55.0%−72.1%−157.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$66.8M$47.8M$63.7M$71.6M$89.1M$44.2M$70.7MPending
Estimate$61.8M$57.0M$66.0M$73.7M$90.0M$52.4M$70.4M$99.1M
Surprise+8.2%−16.1%−3.4%−2.8%−1.0%−15.7%+0.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $1.41 | — | — |
| Sep 2028 | $0.76 | — | — |
| Jun 2028 | $0.35 | — | — |
| Mar 2028 | $0.22 | — | — |
| Dec 2027 | $1.05 | — | — |
| Sep 2027 | $0.59 | — | — |
| Jun 2027 | $0.32 | — | — |
| Mar 2027 | −$0.14 | — | — |
| Dec 2026 | $0.90 | — | — |
| Nov 2026 | $0.16 | — | — |
| Aug 2026 | −$0.18 | −$0.46 | −157.3% |
| May 2026 | −$0.43 | −$0.74 | −72.1% |
| Mar 2026 | $0.40 | $0.18 | −55.0% |
| Nov 2025 | $0.22 | $0.03 | −86.4% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $1.41 | — | — | $224.7M | — | — | — |
| Sep 2028 | $0.76 | — | — | $175.8M | — | — | — |
| Jun 2028 | $0.35 | — | — | $155.6M | — | — | — |
| Mar 2028 | $0.22 | — | — | $116.0M | — | — | — |
| Dec 2027 | $1.05 | — | — | $171.0M | — | — | — |
| Sep 2027 | $0.59 | — | — | $137.1M | — | — | — |
| Jun 2027 | $0.32 | — | — | $120.3M | — | — | — |
| Mar 2027 | −$0.14 | — | — | $89.8M | — | — | — |
| Dec 2026 | $0.90 | — | — | $136.8M | — | — | — |
| Nov 9, 2026 | $0.16 | — | — | $99.1M | — | — | — |
| Aug 10, 2026 | −$0.18 | −$0.46 | −157.3% | $70.4M | $70.7M | +0.4% | −3.1% |
| May 11, 2026 | −$0.43 | −$0.74 | −72.1% | $52.4M | $44.2M | −15.7% | −23.7% |
| Mar 2, 2026 | $0.40 | $0.18 | −55.0% | $90.0M | $89.1M | −1.0% | −28.0% |
| Nov 10, 2025 | $0.22 | $0.03 | −86.4% | $73.7M | $71.6M | −2.8% | +13.5% |
| Aug 11, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 20, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 23, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 10, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 8, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 13, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 12, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 6, 2018 | |||||||
| May 15, 2018 | |||||||
| Mar 8, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 10, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 21, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 15, 2016 | |||||||
| May 12, 2016 | |||||||
| Mar 23, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 12, 2015 |